Link Between Metabolic Biomarkers and Breast Cancer
Author Information
Author(s): Wang Bowen, Ling Yue, Zhang Hui, Yang Ming
Primary Institution: First Hospital of Jilin University, Changchun, Jilin, China
Hypothesis
This study aims to investigate the genetic relationship between metabolites and breast cancer using Mendelian randomization analysis.
Conclusion
The study demonstrates a genetic causal relationship between most metabolites and breast cancer, confirming the link between these factors.
Supporting Evidence
- 59 biomarkers demonstrated significant causal relationships with breast cancer.
- 60 biomarkers were found to have a causal association with ER + breast cancer.
- 30 biomarkers demonstrated a causal link with ER- breast cancer.
Takeaway
Scientists looked at how certain substances in the blood might cause breast cancer, and they found that many of these substances are connected to the disease.
Methodology
The study used Mendelian randomization analysis with data from genome-wide association studies to assess the causal relationship between 233 metabolites and breast cancer.
Potential Biases
Potential horizontal pleiotropy where genetic variants might influence multiple traits through unrelated pathways.
Limitations
The study's findings may not be generalizable to different populations due to variations in genetic background and lifestyle factors.
Participant Demographics
Participants included 136,016 individuals from various cohorts, with breast cancer data sourced from 122,977 cases and 105,974 controls of European ancestry.
Statistical Information
P-Value
p<0.05
Confidence Interval
95% CI: 0.837–0.970
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website